Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121757) titled 'The half-maximal effective concentration of cyclobutanol TCI in inhibiting cardiovascular responses during double-lumen endotracheal intubation when combined with sufentanil and remimazolam' on April 2.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Affiated Cancer Hospital of Guizhou Medical University

Condition: None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-03

Target Sample Size: Experimental group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=314947

Disclaimer: Curated ...